The CCL5-CCR5 pathway has been demonstrated to promote tumor invasiveness by activating intracellular calcium cascade (increased calcium levels) and CaMKII (Calcium/Calmodulin Dependent Protein Kinase Kinase II)-dependent matrix metalloproteinase 2 (MMP2) upregulation in tumor cells (103). This evidence concerns the gene CCR5 and neoplasm.